Specimen Radiography Systems Market Assessment and Key Insights Analyzed Till 2029

Specimen radiography systems is a medical device which is used for imaging the breast biopsy cores. Also surgically excise tissue specimen will be analyzed using specimen radiography systems. Specimen radiography systems are available in in for standalone and portable form. Specimen radiography systems include 8-by-8-inch camera and 16-bit contrast resolution which provide clear imaging of breast biopsy.  Along with that, Specimen radiography systems consist of a lighted specimen X-ray chamber, X-ray automatic exposure controls, and large active imaging area.Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-10411

Smallest micro clarification of large specimen can be done by using specimen radiography systems. Specimen radiography systems can also generate the HD images of specimen and can send these images directly to PCAS. The use of specimen radiography systems for mammographic screening have improved the diagnostic method and provide an advent for early detection of breast cancer.

Specimen Radiography Systems Market: Drivers and Restraints

Rising prevalence of breast cancer is the primary factory driving the growth of Specimen Radiography Systems market. Also, rising adoption of specimen radiography systems for mammographic screening will fuel the growth of Specimen Radiography Systems market. Moreover, technological advancements also boosting the revenue growth for Specimen Radiography Systems market. Additionally, availability of favourable reimbursement scenario for the treatment of breast cancer will upsurge the demand for Specimen Radiography Systems market. Additionally, rising awareness among the people about the breast cancer due launch of several awareness campaign by NGO in both developed and developing countries. On other hand, Uncertainty in product approval by FDA can restrain the growth of Specimen Radiography Systems market.

Specimen Radiography Systems Market: Overview

The specimen radiography systems market is expected to show exponential growth over the forecast period due to rising patient pool suffering from of breast cancer. Breast cancer is the most common cancer among the woman as the research by World Cancer Research Fund International. The same organization also stated that 19.3 per 100,000 women are suffering from breast cancer throughout the globe.  According to Union Health Ministry of India, around 25.8 per 10,000 women are suffering from cancer in India. Among all end user breast clinics segment of tissue market is anticipated to grow at faster pace that other segment over the forecast period.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-10411

Specimen Radiography Systems Market: Regional Overview

North America is expected to be most dominant region for Specimen Radiography Systems market due technological advancement in U.S. and Canada. After North America, Specimen Radiography Systems market is then followed by Europe owing to increasing adoption for Specimen Radiography Systems and availability of favorable reimbursement scenario in this region. Asia-Pacific is expected to show significant growth for Specimen Radiography Systems market due rising prevalence of breast cancer in India and China. Latin America and Middle East and Africa region are expected to show delayed growth for Specimen Radiography Systems market owing to lack awareness among the people in this region.

Specimen Radiography Systems Market: Key Players

Examples of some of the market participants in Specimen Radiography Systems market identified across the value chain Progressive Medical Corp., Hologic, Inc., Simeks T?bbi Sistemler Sanayi ve Ticaret A.?., KUB Technologies, and others.

The research report on Specimen Radiography Systems market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on Specimen Radiography Systems market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on Specimen Radiography Systems Market:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Report on Specimen Radiography Systems market includes regional analysis:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, , Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on Specimen Radiography Systems market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-10411

Specimen Radiography Systems Market: Segmentation

The global Specimen Radiography Systems market is classified on the basis of modality, end user and geographic region

Based on modality, Specimen Radiography Systems market is segmented into following:

  • Trolley Mounted
  • Wall Mounted

Based on end user, Specimen Radiography Systems market is segmented into following:

  • Hospitals
  • Breast Clinics
  • Ambulatory Surgical Centers

Report on Specimen Radiography Systems market highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Instrument Cleaners and Detergents Market is revenue expected to reach US$ 840.8 Million over the forecast 2031

Increase in incidence of hospital-acquired infections is enabling growth in the instrument cleaners and detergents market, which is expected to reach US$ 2.02 Bn in 2021. The market is projected to register growth at a positive pace between 2021 and 2031, driven by the increasing occurrence of hospital-acquired infections (HAIs).

Hospital-acquired infections have emerged as a key health concern, influencing patient recovery that has a significant effect on mortality recorded worldwide. In addition, the increase in the occurrence of surgical site infections is expected to drive the market.

Hospitals utilize various medical instruments during the course of treatment and diagnosis of the patients. These medical instruments ought to be disinfected and cleaned on daily basis which requires the detergents and cleaners.

Apart from this, rising cases of chronic diseases, growing overall population, and improving medical care awareness among general people are some of the primary reasons driving the instrument cleaners and detergents market.

Spurred by favorable trends, some of the leading pharmaceutical companies are focusing on expanding their product scope across various distribution channels. Currently, the market can be broadly categorized into cleaners and detergents in terms of products. Of these, detergents are forecast to account for over 73% of sales in the market by 2031.

Rising demand from hospitals and various other healthcare institutions will remain a chief growth driver. Amid COVID-19 outbreak, focus on sanitization is at all-time high. This has caused the sales of instrument cleaners and detergents to soar as well.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10828

Key Takeaways from Instrument Cleaners and Detergents Market Study

  • Instrument cleaners and detergents market will register 4.1% CAGR between 2021 and 2031, thanks to higher focus on curbing the incidence of infection in healthcare institutions
  • Demand from hospitals will continue rising. Hospitals are likely to emerge as dominant end user and reach a market value of US$ 1.1 Bn by 2031
  • The U.S. is the most lucrative market in the global instrument cleaners and detergents market and is expected to grow at a CAGR of 4.4% between 2021 and 2031
  • After a period of positive growth, the demand will drop slightly in the U.K. In 2021, the U.K. market is expected to register 3.7% y-o-y growth
  • China and Japan are likely to dominate sales registered in East Asia

“Expansion of the healthcare sector globally, increasing cases of hospital acquired infections, rise in the prevalence of surgical site infections, and increasing investments by governments to improve healthcare infrastructure will present a conducive environment for increasing sales of instrument cleaners and detergents,” says the FMI Analyst

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-10828

Key Participant Insights

The instrument cleaners and detergents market is set to expand in the forecast period, as a result of rising prevalence of various infectious diseases, and growing investment in R&D. Some of the leading companies are actively engaging into acquisitions and expansion in order to enhance their product portfolio and outreach. The key market players covered by FMI include Metrex Research, LLC , Ruhof Corporation, Case Medical, Inc., Certol International LLC, Dr. Weigert, Biotrol, ORO Clean Chemie AG, Medalkan, STERIS Plc, Getinge Group, Ecolab Inc., 3M Co., Cantel Medical Corporation, EQT (Schülke & Mayr

Some of the leading players operating in the market are concentrating on rising acquisitions at territorial levels. The pattern is mainly seen across Europe and North America. Acquisitions offer organizations the scope to expand portfolio. It is therefore one of the key strategies adopted by the market players to strengthen their footprint. For instance:

  • In, January 2021, STERIS Plc and Cantel Medical Corp  announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary.  Cantel is a global provider of infection-prevention products and services, primarily to endoscopy and dental Customers.
  • In December 2020, CANTEL MEDICAL CORP. and Censis Technologies announced a new long-term partnership to combine Cantel’s leading infection-prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

Instrument Cleaners and Detergents Market by Category

By Product Type:

  • Cleaners
    • Liquid Solutions
    • Foam-based Cleaners
    • Gel-based Cleaners
  • Detergents
    • Enzymatic Detergents
    • Neutral Detergents
    • Acidic Detergents
    • Alkaline Detergents

By Process Type:

  • Presoak
  • Manual cleaning
  • Automatic Cleaning
  • Disinfection

By Instrument Type:

  • Surgical instruments
  • Endoscopes
  • Ultrasound
  • Dental Instruments
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Specialty Clinics
  • Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-10828

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Biological & Chemical Indicators Market 2021 End-User Demand by Types, Regions,Top Players, Service Provides, Regional Outlook and Forecast to 2030

According to Future Market Insights (FMI) the worldwide yearly tracker, vendor revenue in global biological & chemical indicators market will grow 9.1% year over year to 396.8 Mn in 2020. Global shipments will rise 9.7% year over year to 830.7 Mn units in 2020.

Irrespective of the COVID-19 pandemic, demand for biological and chemical indicators has been surging tremendously as sterilization has always been at forefront of duties of healthcare facilities.

However, the role will be put to test in near future as epidemiological numbers continue to rise amidst the public health crisis. As such, FMI foresees healthy growth trail for global biological and chemical indicators market over forecast period 2020-2030.

Biological & Chemical Indicators Market Size Study

  • Thermal sterilization will remain preferred sterilization type through 2030
  • Biological indicators (BI) continue to stay high in demand, enzyme indicators to gain traction
  • Players to stay glued to self-contained BIs, as they lead to shorter required incubation times
  • Biopharma industry to remain primary end user of biological and chemical indicators over following decade
  • Stakeholders to reap substantial revenue from North America and Europe, given presence of advanced healthcare infrastructure

“After oral administration, parenteral dosage is the most prevalent way of providing drugs to patients. At present, about 95% of recently approved biopharmaceuticals are parenteral dosage form. This rise in commercialization and manufacturing of parenteral drugs will propel the adoption of biological and chemical indicators in biopharmaceuticals companies,” says analyst at FMI.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12544

COVID-19 Impact on Biological & Chemical Indicators Market

The COVID-19 pandemic will trigger the demand for biological and chemical indicators for short-term to validate sterilization process in hospitals, ambulatory surgical centers (ASC), and clinics.

The pandemic has put pressure on frontline healthcare workers to follow strict cleaning and disinfection protocols as they are specifically at risk of contracting and spreading the infection. This has triggered the need for sterilization measures enacted during surgical procedures due to concerns of COVID-19 transmission among hospitalized patients.

The World Health Organization (WHO) has advised personal protective equipment (PPE) industry and governments to ramp up their manufacturing by 40% to cater to surging worldwide demand. This high pool of medical equipment with need for proper sterilization will bode well for biological & chemical indicators market in immediate future.

Biological & Chemical Indicators Market – Competitive Intelligence

The global biological & chemical indicators market is highly consolidated with top 5 players – 3M Company, Steris Plc., and Thermo Fisher – collectively accounting for around 4/5 of overall market revenue. In order to sustain competition due to increasing number of new and small companies, leading players are focusing on mergers and acquisitions (M&A). For instance,

  • Thermo Fisher Scientific Inc. has acquired QIAGEN N.V. – leading worldwide provider of sample preparation and molecular diagnostics technologies. This acquisition will enable the company to leverage its industry-leading capabilities and R&D expertise to speed up innovation and deal with emerging healthcare needs.
  • McKesson Medical-Surgical Inc. has entered into an agreement with Walgreens Boots Alliance to combine their respective pharmaceutical wholesale businesses in Germany.
  • Cantel Medical has taken over Hu-Friedy, which manufactures dental instruments and reprocessing equipment.

Future Market Insights, in its new study, provides compelling insights about the biological & chemical indicators market that encloses industry analysis for 2015 – 2019 and opportunity assessment for 2020 – 2030. The report offers unbiased assessment on biological & chemical indicators market through five different categories – sterilization type, indicator class, packaging form, end user, and region. The global biological & chemical indicators market research study delivers insights of pricing by different life cycle analysis, product life cycle, major market trends and technologies that are being utilized in the development of biological & chemical indicators and product adoption in various end users.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12544

Biological & Chemical Indicators Market Segmentation

Sterilization Type

  • Thermal Sterilization
    • Steam Heat
    • Dry Heat
  • Chemical Sterilization
    • Ethylene Oxide
    • Hydrogen Peroxide
    • Formaldehyde
  • Radiation Sterilization

Indicator Class

  • Biological Indicators
    • Bacillus atrophaeus (BA) Spores
    • Geobacillus stearothermophilus (GS) Spores
    • Others
  • Chemical Indicators
    • Class 1 (Process)
    • Class 4 (Multi-Variable)
    • Class 2 (Specific-Use)
    • Class 3 (Single-Variable)
    • Class 5 (Integrating)
    • Class 6 (Cycle Verification)
  • Enzyme Indicators

Packaging Form

  • Self-Contained BI
  • Spore Suspension BI
  • Strip and Disc BI
  • Strip and Disc CI
  • Others

End User

  • Biopharma Industry
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Labs
  • Research Labs

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/12544

Regional Outlook

  • North America (US, and Canada)
  • Latin America (Brazil, and Mexico)
  • Europe (Germany, UK, Russia, France, and Italy)
  • South Asia (India, Indonesia, Thailand, Australia and New Zealand)
  • East Asia (China, Japan, and South Korea)
  • Oceania (Australia and New Zealand)
  • Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)

Service Orchestration Market Is Projected To Increase At A Prolific 26.3% CAGR Between 2021 And 2031

According to newly released data on service orchestration market analysis by Future Market Insights (FMI), demand for service orchestration is projected to increase at a prolific 26.3% CAGR between 2021 and 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13147

Rapid advancements in cloud computing technologies, along with increasing adoption of business automation services in organizations will continue pushing sales of service orchestration solutions. Considering this, FMI has forecast the total market valuation to surpass US$ 4.1 Bn in 2021.

Over the past few years, development of service orchestration architectures and interfaces has been accelerating. A key motive of service orchestration is to enable dynamic and flexible resource control and monitoring mechanisms.

Organizations continually seek to improve cost efficiency as they scale, and service orchestration enables them to achieve their goals by delivering those improvements with predictability and reliability.

Service orchestration reduces cost of network ownership and delivers on-demand services to a broad range of businesses. Moreover, multi-domain service orchestration ensures software development and integration support to streamline service activation and enhance agility. Owing to these factors, sales of service orchestration in large and small/medium enterprises (SMEs) are projected to rise over the forecast period.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13147

The introduction of the cloud computing technologies has provided organizations with a reliable, effective solution to deliver essential capabilities and services to their customers, at scale. Cloud has become an intrinsic part of modern business. Cloud computing gives organizations the ability to improve their operational efficiency, cut costs, and increase data and processing flexibility.

With huge amount of data generated through multiple cloud environments, maintaining the coherent cloud processes has become a difficult task. To meet these challenges, organizations are continuously integrating advanced service orchestration platforms, which will continue augmenting growth of the market in the forthcoming years.

“Increasing demand for cloud-based services for streamlining data sharing, along with rising adoption of 5G technology and edge computing will continue augmenting growth of the service orchestration market through 2031,” says an FMI analyst.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-13147

Key Takeaways:

  • By solution, the service orchestration platform segment is anticipated to expand at a 23.2% CAGR through 2031.
  • The large enterprise segment is projected to hold 57.5% of the total service orchestration market share.
  • Demand for cloud-based services is expected to grow at a stupendous 25.8% CAGR through 2031.
  • Applications of service orchestration in the IT and telecom sector are expected to remain high, enabling sales at a 29.9% CAGR over the forecast period.
  • The U.S. is anticipated to dominate the North America service orchestration market, accounting for 88.9% of the market share through 2031.
  • Sales of service orchestration solutions in the U.K. are projected to increase at a 30.2% CAGR.
  • China will emerge as an attractive service orchestration market, accounting for 58.8% of the East Asia market share in 2031.
  • Demand for service orchestration in Japan and South Korea is forecast to grow at 21.8 CAGR and 25.9% CAGR respectively.

Localized Temperature Therapy Products Market Key Players – Medtronic Plc, Kobayashi Pharmaceutical Co. Inc., Cardinal Health, Carex Health Breg Inc., Medline Industries Inc., Core Products International Inc.

Localized temperature therapy products display high efficacy in non-invasive pain management and hypothermia prevention applications. According to a new Future Market Insights study, the industry will display substantial scope in applications for localized neonatal therapy, and for sport injury treatments in the near future.

Growing applications in healthcare, coupled with growth of the global manufacturing sector and favorable policies by governments, are generating lucrative growth opportunities, especially in developing economies across Asia and Latin America. Also, therapeutic applications aimed towards geriatric users will support long term growth prospects.

Future Market Insights, in its study has estimated the market to rise at 6% CAGR between 2020 and 2030. Market players operating in the industry are aiming for the development of product improvements through novel technologies in addition to industry collaborations and capacity expansions to keep pace with changing industry needs.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5053

The market has witnessed substantial expansion in recent years, with better access to healthcare services for injury and pain relief therapeutics. Higher popularity of non-surgical, pharmaceutical-free treatments for physical injuries and chronic ailments such as arthritis and osteoporosis, has been driven by reduced risk of side effects, and ease of application.

Localized temperature therapy aids help to improve blood and oxygen flow. Innovations such as microwave and electric products provide higher efficacy and are gaining from wider scope of application. Rising incidences of road accidents, and sport injuries result in bone and tendon ruptures, strains, and sprains, which boost overall market demand. On the other hand, alternatives such as reusable packs and herbal medication could restrict growth.

FMI’s report on the market offers a detailed overview, covering essential market dynamics. Some of the major takeaways from the report are as follows:

  • The value of the localized temperature therapy products market for in 2019 was over US$ 1.4 Bn, which higher than previous years
  • Hospitalization for hypothermia and chronic pain for adult populations are driving growth through the forecast period
  • Back and knee pain management applications are picking up pace with higher demand arising from geriatric users
  • North America is projected to remain dominant, with the United States displaying highly lucrative market growth opportunities

“Apart from the high demand for injury and pain management healthcare operations, the rise in the number of premature births globally and the resultant preterm birth complications, particularly in emerging economies will be a major factor boosting the application of localized temperature therapy products for neonatal treatments,” said an analyst at FMI.

COVID-19 Impact on Localized Temperature Therapy Products Market

The covid-19 virus, which causes acute respiratory distress has been found to be sensitive to heat. Consequently, the use of higher temperatures tolerable to the human body has been found to be effective in destroying and deactivate the lipid covering of the virus. This factor is expected to have a positive impact on the localized temperature therapy product market in providing patient short-term relief.

On the other hand, the restrictions imposed by governments on elective medical procedures during the crisis is likely to impact short term sales. Also, the pandemic has affected neonatal infant care, with pediatric patients and newborns being at higher risk of infection, leading to the establishment of standards of testing and care, which could support market growth throughout the duration of the pandemic.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5053

Key Players: 

Medtronic Plc, Kobayashi Pharmaceutical Co. Inc., Cardinal Health, Carex Health Breg Inc., Medline Industries Inc., Core Products International Inc., Cincinnati Sub Zero, The Mentholatum Company, B.u.W. Schmidt, Life Wear Technologies, Pic Solution, Advanced Home Care, Rapid Aid, Adroit Medical Systems and Macon & Company Inc.

Key Segments

Product Type

  • Localized Neonatal Therapy Product
  • Warming Mattress
  • Infant Heel Warmers
  • Localized Heat Therapy Product
  • Hot Water Bottles
  • Heat Lamps
  • Paraffin Bath
  • Gel Hot Packs
  • Localized Cold Therapy Product
  • Vapocoolant Sprays
  • Thermal Cooling Blanket
  • Disposable Ice Bags
  • Cold Packs

Area of Application

  • Neck
  • Shoulder
  • Knee
  • Back
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5053

Regional Outlook

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Rest of LATAM)
  • Europe (Germany, U.K., France, Italy, Spain, BENELUX, Russia, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Indonesia, Rest of South Asia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, Turkey, South Africa, Rest of MEA)

Lithium Mining Market is expected to top US$ 3.3. Bn by 2031, Exclusive Report By Future Market Insights

As per FMI, the global lithium mining market is projected to reach US$ 1.65 billion in 2021. Growing application across glass & ceramics, polymer, and pharmaceutical industries is favoring lithium sales. Driven by this, the market is estimated to reach US$ 3.3 billion by 2031, expanding at a CAGR of 7.2% over the forecast period 2021-2031.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-14064

More than half of the total lithium produced around the world is used for manufacturing batteries owing to its strong electrochemical potential and lightweight. Increasing demand for li-ion batteries across consumer electronics such as smartphones and laptops, and medical devices such as mobile diagnostics devices and others is accelerating the market growth. As per FMI, the sales of lithium are expected to showcase year-over-year growth of 8.5% in 2021 across the battery industry.

Sales for electric vehicles are increasing as automotive manufacturers look for solutions to offer greater fuel efficiency and comply with stringent emission control regulations implemented by governments. According to the International Energy Agency, around 7 million electric vehicles (EV) were sold in 2019. This rise in sales is propelling the demand for the EV components including batteries, which is consequently, creating high opportunities for the growth of the market.

Based on type, lithium hydroxide is anticipated to remain a dominant segment in the global market. The growth of the segment is attributed to the increasing applications in air conditioning, glass and ceramics, refrigeration, and battery manufacturing.

“Leading companies are focusing on acquiring more land for increasing their production capacity and adopting advanced technologies for optimizing the recovery of lithium. Through this, they intend to meet surging demand from the battery industry,” says a FMI analyst.

Key Takeaways from Lithium Mining Market Study

  • The U.S. is anticipated to lead the market in North America, registering a year-on-year growth of 3.2% through 2021.
  • Australia, being the leading producer and exporter of lithium in the world, is expected to account for a substantial revenue share in South Asia Pacific market.
  • China is projected to emerge as a highly remunerative market in East Asia, favored by the increasing lithium-ion battery applications across the electric vehicle sector.
  • South Korea and Japan are forecast to collectively account for 11% of the total sales, owing to the surging demand from consumer electronics and medical devices in the country.
  • In terms of source, lithium brine is estimated to hold the largest revenue share in the segment, accounting for 65% of the overall sales through 2021.

Discover more about the lithium mining market analysis with figures and data tables, along with the table of contents. https://www.futuremarketinsights.com/reports/lithium-mining-market

Key Drivers

  • Rising sales of smart wearables and portable consumer electronics in countries such as China, Japan, the U.S., and Germany is fuelling the demand for lithium.
  • Increasing mining activities and governmental investment across the mining industry are expected to facilitate the growth of the market.

Key Restraints

  • Implementation of stringent regulation to curb water pollution caused by the washing of lithium brines and hard rock is hampering the market growth.
  • Side effects associated with lithium carbonate such as hand tremors, diarrhea, lack of coordination, muscular weakness, and increased urination is hampering the sales of lithium across the pharmaceutical sector.

Competitive Landscape

As per FMI, key companies operating in the global market are Jiangxi Ganfeng Lithium Co. Ltd., Albemarle, Tianqi Lithium, Sociedad Química y Minera de Chile, and Pilbara Mineral. These players are estimated to account for 50 to 55% of the total lithium sales through 2031.

Leading manufacturers are focusing on adopting strategies such as collaborations, agreement, mergers and acquisitions to expand their production facilities to address the growing demand. For instance,

  • In September 2021, Albemarle Lithium UK, a global specialty chemicals company, announced entering into an agreement with a lithium convertor based in China, Guangxi Tianyuan New Energy Materials Co., Ltd for acquiring all outstanding equity. . Under the agreement, Albemarle will complete the acquisition in 2022.
  • In April 2021, Tianqi, a Chinese mining and manufacturing company, announced acquisition of an Australian mining company, IGO Ltd, to expand its production capacity of lithium hydroxide.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14064

Some of the key players operating in the market profiled by FMI are:

  • Albemarle
  • Ganfeng Lithium
  • Livent
  • Nemaska Lithium
  • Orocobre limited
  • Sichuan Tianqi Lithium Industries
  • SQM
  • Lithium Americas Corp
  • Tianqi Lithium
  • Ganfeng Lithium Co., Ltd.
  • General Lithium Corp
  • LITHIUM EXPLORATION GROUP
  • LSC Lithium Corporation
  • Neo Lithium Corporation
  • U.S. Lithium Corp
  • Yacimientos de Litio Bolivianos

More Valuable Insights on Lithium Mining Market

FMI, in its new report, offers an unbiased analysis of the global lithium mining market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in lithium mining market with detailed segmentation:

By Source:

  • Brine
  • Hard Rock
  • Others

By Type:

  • Lithium Carbonate
  • Lithium Hydroxide

By Application:

  • Battery
  • Ceramics and Glass
  • Lubricants & Grease
  • Polymer
  • Flux Powder
  • Refrigeration
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14064

Key Questions Covered in the Report

  • The report offers insight into lithium mining market demand outlook for the forecast period 2021-2031
  • The market study also highlights projected sales growth for lithium mining market between 2021 and 2031
  • Lithium mining market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Lithium mining market share analysis, covering key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Infection Prevention Market : Notable Developments & Geographical Outlook 2021 to 2031

According to a recent study by Future Market Insights (FMI), sales of infection prevention products are expected to top US$ 37.4 Bn in 2021, at a CAGR of over 4.2% during the forecast period (2021-2031).

Rising cases of infectious diseases caused due to the pathogenic organisms such as bacteria, fungi, viruses and other parasitic organism are improving the adoption of infection preventing products.

As reported by the Centre for Disease Control and Prevention (CDC) in 2018, infectious disease is the third most leading cause of death in the U.S. followed by other infectious diseases such as tuberculosis (9,025 cases), salmonella (60,99 cases), Lyme disease (33,666 cases), meningococcal disease (327 cases) and parasitic diseases (15.5 Mn cases).

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950

Several other factors such as rising incidence of infections acquired while in hospital (often called as Hospital Acquired Infections or HAI), large number of surgical procedures, and increasing cases of chronic diseases among geriatric population have led to higher emphasis on maintaining proper hygiene and cleanliness.

Sudden outbreak of pandemic increased the number of patients in hospital during the FQ-20, elevating the risk of viral transmission amongst them. This in turn has created the demand for infection preventing and controlling options such as the use of hand sanitizers, disinfectants and other such products.

infection prevention market characteristics and attributes with regional relevance 2021

Increase in sales of these infection prevention products is expected to boost the infection prevention market growth in near future. The market registered spike in demand for infection preventive products, especially in emerging economies such as India.

As per Future Market Insights, the India infection prevention market registered highest growth across South Asia, reaching US$ 17.29 Bn in 2021.

Additionally, companies manufacturing infection prevention products have been focusing on developing eco- friendly and sustainable bio-based products with superior efficacy. Drive towards sustainability is expected to strengthen infection prevention market, creating worthwhile opportunities for growth.

Increasing ageing population worldwide has resulted in higher focus on proper hygiene and self-care solutions due to the rise in chronic diseases and onset of COVID-19. Furthermore, increase in consumer spending, improved healthcare infrastructure, rising government and industry investments in research and development activities will create demand for infection prevention product.

Based on the aforementioned factors, Future Market Insights (FMI) estimates that the market is expected to create absolute $ opportunity, exceeding more than US$ 56.39 Bn by 2031-end.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13950

Key Takeaways from Infection Prevention Market Study

  • By product, sterilization equipment is the most lucrative segment in terms of revenue and is anticipated to grow at a CAGR of more than 4.9% during 2021-2031.
  • Based on end-user, hospitals and clinics segment is leading the market and expected to gain more than 42% of revenue share through 2031.
  • The U.S. is expected to dominate the global infection prevention market in terms of revenue in 2021, followed by the U.K. and Germany.
  • India is expected to be the most lucrative market in terms of revenue across South Asia, accounting for over 50% of market value share in 2021.
  • China holds leading position in East Asia and is expected to account for nearly 48% of market share.

“Backed by the unprecedented outbreak of COVID-19, demand for infection preventing products is increasing. Key players are introducing products made from sustainable and eco-friendly materials to gain competitive edge,” says the FMI Analyst.

Who is Winning?

Some of the leading manufacturers of infection prevention products are focusing on new product development, clinical trials, speedy regulatory approvals, exclusive marketing and distribution licensing agreement strategies, thereby enhancing their market presence.

  • In 2021, a new 3M™ Clean & Protect Certified Badge Program was launched by 3M company. A new comprehensive system designed for effective cleaning and disinfecting solution that cleans, monitors and protects the facilities.
  • In July 2020, Reckitt Benckiser Group PLC in partnership with water.org made provisions for improved access to safe, clean water in Kenya. In the same month, the company received the EPA approval for the first surface disinfectant products tested on the SARS-COV-2 virus.
  • In 2021, Metrex collaborated with Solvay for chemical resistance testing of widely-used disinfectants in healthcare settings.

The key market players covered by FMI include Cantel Medical, Getinge AB, STERIS, ASP (Advanced sterilization Products), Sotera Health, 3M, Ecolab, Halyard Worldwide, Inc. (Halyard health), Matachana Group, Belimed, Inc., Pal International, Reckitt Benckiser Group PLC., Metrex Research, LLC., Terumo Corporation, Ahlstrom Munksjo and Ansell Ltd.

Infection Prevention Market by Category

By Product:

  • Sterilization Equipment
    • Low Temperature Equipment
      • Ozone Sterilizers
      • Hydrogen Peroxide Sterilizers
      • Formaldehyde Sterilizers
      • Ethylene Oxide Sterilizers
      • Other Low-Temperature
    • Heat Sterilization Equipment
      • Moist Heat Sterilizers
      • Dry Heat Sterilizers
    • Radiation Sterilization Equipment
    • Liquid Sterilization Equipment
  • Disinfectors
    • Washer Disinfectors
    • Endoscope Repressors
    • Flusher Disinfectors
    • Surface Disinfectants
    • Hand Sanitizers
  • Consumables
    • Sterilization Supplies
      • Sterile Containers
      •  Sterilization Wrap
      • Sterilization Indicators
  • Protective Apparel & Textiles
    • Surgical Gloves
    • Surgical Drapes
    • Surgical Gowns
    • Surgical Masks
  • Infectious Waste Disposal

By End User:

  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Clinical Laboratories
  • Medical Device Companies
  • Life Sciences Industries
  • Academic and Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13950

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Dog Gates, Doors & Pens Market is anticipated to exhibit healthy expansion, surpassing valuation of 8.9 Bn during the forecast period of 2021 and 2031

Future Market Insights, Dubai: ESOMAR-certified consulting firm Future Market Insights’ report on global dog gates, doors, & pens market projects a staggering growth, topping a valuation of approximately US$ 8.9 Bn over the forecast period of 2021 and 2031.

Growing adoption of dogs across the globe and technological innovation in the products are the major factors propelling growth. Increasing pet humanization among millennials, especially across India, Brazil, and Australia, are increasing the consciousness regarding the pet welfare.

On the back of the aforementioned factor, demand for dog gates, doors, & pens will surge at over 6.6% CAGR during the forecast period. With increasing social media penetration, millennials are increasingly becoming aware regarding their responsibilities towards animals.

Increasing initiatives undertaken by animal rights activists and growing adoption of shelter animals have encouraged the millennials to adopt dogs as pets. Thereby, increasing the sales of dog doors and pens.

As per the FMI’s analysis, due to the onset of the novel COVID-19, the global dog gates, doors, & pens sales grew moderately as manufacturing activities were disrupted. However, adoption of pets surged, especially across India and Brazil, which boosted the demand for dog pens.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12017

Key Takeaways from FMI’s Dog Gates, Doors, & Pens Market Study

  • In terms of sales channel, online retail stores are expected to dominate the segment over the forecast period
  • Modern trade sales channel segment will hold the largest share in the market during the forecast period
  • Based on type, demand for electronic dog gates, doors, and pens will surge at 9.6% CAGR through 2021 & beyond
  • In terms of product, dog pens segment is expected to hold more than half of market share.
  • India and Australia are expected to emerge as the most lucrative market across South Asia and Oceania
  • Germany is anticipated to hold the largest market share across Europe, accounting for nearly one-fourth of sales.

 “Integration of cutting-edge technologies such as automation and artificial intelligence is fuelling the demand for smart doors. Also, growing concerns for sustainability and safety among pet owners has encouraged market players to introduce smart and energy-efficient dog doors and make them available through online retailers. This is expected to create incremental growth opportunities for the market,” says the FMI analyst. 

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12017

Who is Winning?

Some of the key players operating in the dog gates, doors, & pens market Richell Inc., Midwest Pet Products Inc., Ware Pet Products, FurHaven Pet Products, Endura Flap, Ideal Pet Products, Plexidor, Petsfit Inc., High Tech Pet Products Inc., Hale Pet Door, Takara Industry Co. Ltd., Gun Dog House Door Inc., Carlson Products, ZampaPet, and IRIS USA Inc. among others.

As per the FMI’s analysis, leading players in the market are focusing on product development, and sustainability to introduce new smart products such as smart pet doors integrated with cutting-edge technologies to expand their global footprints.

Also, the market players are adopting expansion strategies such as mergers and collaboration with local and online distributors to cater the surging need amidst the global pandemic. Industry giants are relying on digital marketing and social media platforms to reach global audience and improve their brand awareness.

Get More Insights on Global Dog Gates, Doors, & Pens Market

In its latest report, FMI provides an incisive coverage on the global dog gates, doors, & pens market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (gates, doors, and pens), size (small-sized dogs, medium-sized dogs, large-sized dogs), type (electronic, and non-electronic), sales channel (modern trade, convenience stores, care service centers, car service centers, pet specialty stores, online retail stores, and other sales channel) across seven major regions

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-12017

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

 

Opioid Analgesics Market valuation is projected to total US$ 65.8 Bn in 2031, Says FMI Analyst

As per an exhaustive study by FMI, the Global Opioid Analgesics Market is anticipated to reach US$ 65.8 billion by 2031. In response to surging demand for post-surgery pain management and focus on novel drug formulations for analgesics, the market is estimated to expand at a CAGR of 5.4% over the forecast period 2021-2031, in comparison to the 4.2% CAGR registered from 2016 to 2020.

Opioid analgesics market is largely driven by the increasing prevalence of chronic disorders, neuropathic pain, and orthopedic diseases. Opioids are extensively used for anesthesia, cough suppression, cancer pain management, and treatment of several other conditions. In addition to this, the development of novel analgesics with fewer side effects is expected to spur sales by 1.7X through 2031.

A considerable rise in the number of surgical procedures has been reported in the last few years. According to the International Society of Aesthetic Plastic Surgery (ISAPS), around 11.3 million surgeries were reported across the world in 2019. As opioids are used as medications for managing and reducing pain post-surgeries, the surgical pain indication segment is anticipated to account for nearly 45.9% of the total sales by 2031.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-14043

As per FMI, Europe is projected to account for a considerable share in the global market, exhibiting sales growth at a CAGR of 5.4% between 2021 and 2031. The growth in the region is attributed to the increasing prevalence of chronic diseases and presence of favorable medical reimbursement policies in the U.K and Germany.

“Commercialization of non-abusive opioids and increasing availability of opioid analgesics through online distribution channels are expected to accelerate the sales of opioid analgesics,” says the FMI analyst.

Key Takeaways from Opioid Analgesics Market Study

  • The U.S. is anticipated to lead the market in North America, accounting for nearly 86% of the overall sales in 2021.
  • Sales of opioid analgesics in Germany are estimated to total US$ 2.2 billion, growing at a CAGR of 3.8% during the assessment period.
  • The market in India is forecast to account for 35.4% of the sales in South Asia, expanding at a CAGR of 5.7% between 2021 and 2031.
  • China is expected to emerge as the most lucrative market for opioid analgesics in East Asia, contributing around 54.2% of the sales revenue in the region by 2021 end.
  • Among drug class verticals, oxycodone is estimated to dominate the segment accounting for more than 19% of the global demand in 2021.

Key Drivers

  • Surging demand for facial and body aesthetics in response to the rising number of aesthetic surgical procedures such as breast implantation, eyelid surgeries, and abdominoplasty conducted worldwide will spur the sales across surgical pain segment.
  • Increasing adoption of opioid maintenance treatment (OMT) for treating opioid dependence (OD) across Germany, the U.K., the U.S., and others are anticipated to drive the market growth.

Key Restraints

  • Side effects associated with opioid analgesics such as drowsiness, nausea, constipation, clouded thinking, and psychological & physical addiction are hampering the market growth.
  • Stringent government regulation and guidelines regarding manufacturing, storage, marketing, and selling of opioid products are restraining the growth of opioid analgesics.

Discover more about the opioid analgesics analysis with figures and data tables, along with the table of contents. https://www.futuremarketinsights.com/ask-question/rep-gb-14043

Competitive Landscape

Leading manufacturers are emphasizing on launching new and revised products to enhance their product portfolios. Strategies such as product approvals, partnerships, agreements, merger, facility expansion, and collaborations are expected to assist market players strengthen their footprint and gain a competitive edge over other players. For instance,

  • In May 2020, Assertio Therapeutics, Inc., an American specialty pharmaceutical company, announced entering into merger agreement with a U.S.-based pharmaceutical company, Zyla Life Sciences. The merger will assist companies to expand their product portfolio of inflammation, neurology, and chronic pain medications.
  • In September 2018, Novartis, a Swiss multinational pharmaceutical corporation, announced signing an agreement for marketing, distribution, and sales, of well-known pain medicine brands such as Cataflam (diclofenac potassium) and Voltaren (diclofenac sodium) in Thailand, Malaysia and Philippines.
  • Pfizer Inc.
  • Abbott Laboratories
  • Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG,
  • Boehringer Ingelheim International GmbH
  • Bausch Health Companies Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals
  • AbbVie Inc. (Allergan plc)
  • Purdue Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Ltd.

More Valuable Insights on Opioid Analgesics Market

FMI, in its new report, offers an unbiased analysis of the global opioid analgesics market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in opioid analgesics market with detailed segmentation:

By Drug Class:

  • Morphine
  • Codeine
  • Fentanyl
  • Meperidine

By Indication:

  • Surgical Pain
  • Cancer Pain
  • Neuropathic Pain
  • Other

By Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • Other

By End User:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Get customized report as per your requirement – https://www.futuremarketinsights.com/customization-available/rep-gb-14043

Key Questions Covered in the Report

  • The report offers insight into opioid analgesics market demand outlook for the forecast period 2021-2031
  • The market study also highlights projected sales growth for opioid analgesics market between 2021 and 2031
  • Opioid analgesics market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Opioid analgesics market share analysis, covering key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Nasal Antihistamines Market is expected to register a CAGR of 4.6% during the forecast period 2021-2031

As per a recent survey by FMI, the global Nasal Antihistamines Market is projected to total US$ 1.9 billion in 2021. Rising preference for alternative modes of drug administration other than injectable and oral is propelling the demand for the nasal drug delivery solutions. Driven by this, the market is expected to reach US$ 3.08 billion by the end of 2031.

A significant rise in prevalence of allergies has been witnessed across the world due to the increasing sensitization to allergens and intensifying air pollution. According to the Asthma and Allergy Foundation of America, allergies are the sixth leading cause of chronic illness in the U.S. The country reports over 50 million cases of allergies every year. Increasing demand for speedy relief from allergic reactions such as nose congestion, itchy and runny nose, and sneezing is creating immense sales opportunities for the market.

Several players in the market are focusing on launching novel products to capitalize on this opportunity. For instance, Glenmark Pharma announced launching a new nasal spray named Ryaltris in India in May 2021. In response to a slew of novel product launches, sales are expected to rise at a CAGR of 4.6% during the forecast period 2021-2031.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-13708

As per FMI, nasal sprays are the most preferred product available in the nasal antihistamines market, accounting for around 90% of global sales. Attributes such as fast relief, easy to carry, and cost-effectiveness are accelerating the demand for nasal sprays.

“Growing inclination towards the non-invasive treatments and increasing approvals by the Food and Drug Administration (FDA) for over-the-counter (OTC) sales of prescription-based nasal antihistamines are expected to favor the market growth in the coming years,” says the FMI analyst.

Key Takeaways from Nasal Antihistamines Market Study

  • The U.S. is expected to hold the largest revenue share in the North America market, accounting for 90.7% of sales in the region in 2021.
  • The U.K. is projected to emerge as a highly remunerative market, contributing more than 17.9% of sales in Europe in 2021.
  • The market in China is forecast to witness the fastest growth in East Asia, expanding at a CAGR of 6.5% over the assessment period.
  • Sales of nasal antihistamines in South Korea and Japan are anticipated to rise at 3.8% and 5.3% CAGR, respectively, by the end of the coming decade.
  • Based on distribution channel, retail pharmacies are estimated to account for over 40% of revenue share in the segment, projecting sales growth at a CAGR of 4.4% through 2031.

Key Drivers

  • Increasing healthcare expenditure, ease in product approvals, and rising funding for life science research, and new product launches are expected to accelerate the growth of the nasal antihistamine market.
  • Rising prevalence of respiratory diseases including asthma, allergic rhinitis, and others are fuelling the demand for low-cost generic medical products across China, India, Mexico, Brazil, and South Africa, which is propelling the demand for nasal antihistamines.

Key Restraints

  • Side effects associated with nasal antihistamines such as dizziness, dry mouth, and nose, headache, and others is hampering sales of nasal antihistamines.
  • Availability of alternatives such as oral antihistamines and others are hindering the growth of nasal antihistamines market.

Discover more about the nasal antihistamines analysis with figures and data tables, along with the table of contents – https://www.futuremarketinsights.com/ask-question/rep-gb-13708

Competitive Landscape

As per FMI, the global market is dominated by Bayer Healthcare, Novartis AG, Glenmark Pharmaceuticals, GlaxoSmithKline, Cipla, Merck & Co., Sun Pharmaceuticals, Viatris, Proctor & Gamble, Ascend Laboratories, Centaur Pharmaceuticals, J pharmaceuticals, Sato Pharmaceuticals, and Altair Pharmaceuticals.

Leading players are emphasizing on launching new products and receiving regulatory approvals to expand their product portfolios. Some of the manufacturers are aiming at engaging into strategic collaborations, acquisitions, agreement, and merger to increase their market share and expand their global presence. For instance,

  • In April 2020, Cipla, an Indian multinational pharmaceutical company, announced receiving final approval for its generic version of Proventil® High Functioning Autism (HFA) Inhalation Aerosol, from the U.S. FDA. The product approval will assist the company to strengthen their presence in the U.S. pharmaceutical market.
  • In December 2020, GlaxoSmithKline, a leading pharmaceutical company in India, announced launching a saline wash natural nasal spray, Otrivin Breathe clean. It offers symptomatic relief from allergic rhinitis with moisturizing benefit as it has natural glycerin in it.

Some of the key players operating in the market profiled by FMI are:

  • Bayer Healthcare LLC
  • Novartis AG
  • Glenmark Pharmaceuticals
  • GlaxoSmithKline
  • Sun Pharmaceuticals
  • Cipla
  • Merck & Co.
  • Viatris (Meda Pharmaceuticals)
  • Proctor & Gamble
  • Ascend Laboratories LLC (Alkem Laboratories)
  • Centaur Pharmaceuticals
  • J Pharmaceuticals
  • Alitair Pharmaceuticals
  • Sato Pharmaceuticals

More Valuable Insights on Nasal Antihistamines Market

FMI, in its new report, offers an unbiased analysis of the global nasal antihistamines market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in nasal antihistamines market with detailed segmentation:

By Product:

  • Nasal Spray
  • Nasal Drops

By Age Group:

  • Adult
  • Pediatric

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

We Offer tailor-made Solutions to fit Your Requirements, Request Customization – https://www.futuremarketinsights.com/customization-available/rep-gb-13708 

 Key Questions Covered in the Report

  • The report offers insight into nasal antihistamines market demand outlook for the forecast period 2021-2031
  • The market study also highlights projected sales growth for nasal antihistamines market between 2021 and 2031
  • Nasal antihistamines market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Nasal antihistamines market share analysis, covering key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others